↓ Skip to main content

Dove Medical Press

Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, July 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
50 Mendeley
Title
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
Published in
Pharmacogenomics and Personalized Medicine, July 2020
DOI 10.2147/pgpm.s231475
Pubmed ID
Authors

Megan N Gower, Lindsay R Ratner, Alexis K Williams, Joseph S Rossi, George A Stouffer, Craig R Lee

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 14%
Researcher 6 12%
Student > Doctoral Student 5 10%
Lecturer > Senior Lecturer 2 4%
Unspecified 2 4%
Other 9 18%
Unknown 19 38%
Readers by discipline Count As %
Medicine and Dentistry 11 22%
Pharmacology, Toxicology and Pharmaceutical Science 8 16%
Biochemistry, Genetics and Molecular Biology 4 8%
Unspecified 2 4%
Economics, Econometrics and Finance 1 2%
Other 0 0%
Unknown 24 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2023.
All research outputs
#17,562,823
of 25,748,735 outputs
Outputs from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Outputs of similar age
#279,145
of 433,651 outputs
Outputs of similar age from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 1.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,651 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them